Jon Congleton, CEO: Mineralys Therapeutics MLYS Sell · Filed 25/11/13

Trade details

Type: Insider sale
Amount: $5,145,563.25
Shares · price: 112,275 sh · $45.83 a share
Held after: 664,155 sh
Stock: Mineralys Therapeutics MLYS
Person: Jon CongletonCEO
Trade date: 25/11/11
Filed: 25/11/13
Days to filing: 2 days

Sold 14.5% of holdings

Share of holding sold: 14.5%

Mineralys Therapeutics trades, last 26 weeks

What else happened in Mineralys Therapeutics around then

Filed or reported within 30 days of the trade day · 25/10/12~25/12/11

Jon Congleton's recent trades

Jon CongletonCEO
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$291.4K
10,700 sh
$291.4K
Filed 07/13
Traded 07/13
Jon CongletonCEO
Sell10b5-1 planMineralys Therapeutics
Sell10b5-1 plan
Mineralys Therapeutics
MLYS
$1.5M
58,000 sh
$1.5M
Filed 06/30
Traded 06/30
Jon CongletonCEO
Sell10b5-1 planMineralys Therapeutics
Sell10b5-1 plan
Mineralys Therapeutics
MLYS
$455.9K
17,000 sh
$455.9K
Filed 06/30
Traded 06/30
Jon CongletonCEO
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$2M
75,000 sh
$2M
Filed 06/30
Traded 06/30
Jon CongletonCEO
Sell10b5-1 planMineralys Therapeutics
Sell10b5-1 plan
Mineralys Therapeutics
MLYS
$422K
15,730 sh
$422K
Filed 04/15
Traded 04/13

Jon Congleton, CEO — sold $5.1M of Mineralys Therapeutics MLYS · 14.5% of holdings | Whalegun